Object: Hemodialysis is the common treatment that causes different problems affecting the quality of life (QoL) of chronic kidney disease patients. This study aims to examine the associated factors related to QoL in patients with end-stage kidney disease (ESKD). Methods: The study employed a cross-sectional design and was conducted from January- November 2022. Data was collected from 78 patients who have hemodialysis using a validated KDQOL-SFTM questionnaire version 1.3 often used to assess the QoL for patients on hemodialysis (HD). There was 01 focus group discussion with Chronic Kidney Disease (CKD) patients and 04 in-depth interviews with management staff. T-test and ANOVA were conducted to analyze quantitative variables. Results: Among the 78 study patients, the total QoL in the patients as shown by KDQOL-SFTM was 54.28 ± 4.98. In which, the SF-36 score was 51,27 ± 7,15 and the KDQOL score was 57.29 ± 5.98. Some demographic characteristics were associated with the low QoL score among ESKD patients such as elderly people (aged 60 years old or over), occupation pensioner/elderly, unemployment (p<0.001, t=4.3, 95%Cl: 2.4 to 6.4), and some other characteristics of diseases are longer duration of disease >5 years (p=0.006), duration of HD >3 years (p=0.001); Family factors were also associated with QoL: distance from home to hospital over 5km (p=0.014, t = 2.5, 95% CI: 0.6 to 5.1), family income (poor and near-poor households) (p<0.001, t=-3.7, 95% Cl: -10.4 to -3.1), and Social factors: health insurance benefits 95%, no social support (p<0.001). Management factors: The health insurance's payment policy affects the QoL of CKD patients. Conclusion: The QoL score of patients with ESKD is relatively higher compared with previous studies. Some demographic, disease-related characteristics (duration of disease and treatment), family factors (distance, income), social factors (health insurance, community support), and health insurance payment policy were associated with lower patient of QoL. Keywords: Chronic kidney disease, end-stage kidney disease, hemodialysis, quality of life.
Read full abstract